22. STRUCTURAL AND SPECTROSCOPIC MRI CHARACTERISTICS OF THE BRAIN IN ELDERLY WITH MILD COGNITIVE IMPAIRMENT

Hoang Anh Dao1, Nguyen Hong Luong2, Nguyen Thi Thanh1,2, Vu Dang Luu3,4
1 National Geriatric Hospital
2 Hanoi Medical University
3 Department of Radiology, Hanoi Medical University
4 Center of Radiology, Bach Mai Hospital

Main Article Content

Abstract

Objective: This study aims to compare brain magnetic resonance imaging characteristics between patients with mild cognitive impairment and normal cognitive.


Subjects and methods: The study was conducted on 40 elderly patients with mild cognitive impairment and 40 control patients without cognitive impairment at National Geriatric Hospital from July 2024 to April 2025. Evaluated parameters included: the degree of cortical atrophy in specific brain regions, bilateral hippocampal volumes, and neurochemical ratios such as NAA/Cr, mI/Cr, NAA/mI, and Cho/Cr using structural magnetic resonance imaging and magnetic resonance spectroscopy.


Results: Magnetic resonance imaging findings revealed significantly greater global brain atrophy, as well as atrophy in the temporal and parietal lobes, and reduced hippocampal volumes in the mild cognitive impairment group compared to the control group (p < 0.001). Spectroscopy results showed significantly decreased NAA/Cr and NAA/mI ratios, along with an increased mI/Cr ratio in the mild cognitive impairment group (p < 0.01), indicating neuronal degeneration and increased glial activation. The mI/Cr ratio demonstrated potential in distinguishing mild cognitive impairment from normal aging, with a sensitivity of 75% and specificity of 60% at a cutoff value > 0.615.


Conclusion: Structural magnetic resonance imaging and magnetic resonance spectroscopy indices show promise as potential biomarkers for early diagnosis and differentiation of mild cognitive impairment from normal aging.

Article Details

References

[1] Boyle P.A, Wilson R.S, Aggarwal N.T, Tang Y, Bennett D.A. Mild cognitive impairment: risk of Alzheimer disease and rate of cognitive decline (in eng). Neurology, Aug 8 2006, vol. 67, no. 3, pp. 441-5.
[2] Scheltens P et al. Atrophy of medial temporal lobes on MRI in “probable” Alzheimer’s disease and normal ageing: diagnostic value and neuropsychological correlates (in eng). J Neurol Neurosurg Psychiatry, Oct 1992, vol. 55, no. 10, pp. 967-72.
[3] Koedam E.L et al. Visual assessment of posterior atrophy development of a MRI rating scale (in eng). Eur Radiol, Dec 2011, vol. 21, no. 12, pp. 2618-25.
[4] Petersen R.C et al. Current concepts in mild cognitive impairment (in eng). Arch Neurol, Dec 2001, vol. 58, no. 12, pp. 1985-92.
[5] Belleville S, Gilbert B, Fontaine F, Gagnon L, Ménard É, Gauthier S. Improvement of Episodic Memory in Persons with Mild Cognitive Impairment and Healthy Older Adults: Evidence from a Cognitive Intervention Program. Dementia and Geriatric Cognitive Disorders, 2006, vol. 22, no. 5-6, pp. 486-499.
[6] Kantarci K et al. Risk of dementia in MCI: combined effect of cerebrovascular disease, volumetric MRI, and 1H MRS (in eng). Neurology, Apr 28 2009, vol. 72, no. 17, pp. 1519-25.
[7] Kantarci K et al. Proton MR spectroscopy in mild cognitive impairment and Alzheimer disease: comparison of 1.5 and 3 T (in eng). AJNR Am J Neuroradiol, May 2003, vol. 24, no. 5, pp. 843-9.